Objectives: This article reports results of the first National Institutes of Health-funded prospective interfacility transport study to determine the effect of goal-directed therapy administered by a specialized pediatric team to critically ill children with the systemic inflammatory response syndrome. We hypothesized that goal-directed therapy during interfacility transport would decrease hospital length of stay, prevent multiple organ dysfunction, and reduce subsequent ICU interventions. Design: Before-and-after intervention trial. Setting: During interfacility transport of critically ill patients by a specialized pediatric transport team, back to a tertiary care children's hospital. Patients: Before-and-after intervention trial. Design: Interfacility pediatric transport patients, age 1 month to 17 years, with systemic inflammatory response syndrome. Interventions: Prospective data were collected on all pediatric interfacility transport patients with systemic inflammatory response syndrome transported by the Angel One Transport team at Arkansas Children's Hospital. A 10-month data collection period was followed by institution of a goal-directed resuscitation protocol. Data were subsequently collected for 10 additional months followed by comparison of pre-and postintervention groups. All transport personnel underwent training with didactics and highfidelity simulation until mastery with goal-directed resuscitation was achieved. Measurements and Main Results: All transport patients were screened for systemic inflammatory response syndrome using established variables and 235 (123 preintervention and 112 postintervention) were enrolled. Univariate analysis revealed shorter hospital stay (11 ± 15 d vs 7 ± 10 d; p = 0.02) and fewer required therapeutic ICU interventions in the postintervention group (Therapeutic Intervention Scoring System-28 Scores, 19.4 ± 6.8 vs 17.3 ± 6.6; p = 0.04). ICU stay and prevalence of organ dysfunction were not statistically different. Multivariable analysis showed a 1.6-day (95% CI, 1.3-2.03; p = 0.02) decrease in hospital stay in the postintervention group.
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For information regarding this article, E-mail: stroudmichaelh@uams.edu T he practice of pediatric interfacility transport has changed in recent years. Improvements in equipment, transport vehicles, therapeutic interventions, and education have afforded teams the opportunity to deliver critical care in the field. Recent evidence has shown that specialized teams with such capabilities can impact the outcomes of critically ill children (1) , and current consensus guidelines recommend the use of specialized teams for transport of critically ill children (2) . Evidence has shown that improved monitoring techniques may also impact the care provided during transport (3) . Specialized pediatric transport teams are becoming mobile ICUs capable of delivering state-of-the-art ICU-level interventions at referring facilities and during transport. Timely intervention is necessary to optimize the outcomes of critically ill children during transport.
Goal-directed therapy has been instrumental in improving the outcomes of adults and children with severe sepsis and septic shock (4) (5) (6) . Systemic inflammatory response syndrome (SIRS) is a precursor to severe sepsis and septic shock. This constellation of clinical findings was developed by a joint consensus conference by the American College of Chest Physicians and the Society of Critical Care Medicine to describe the complex host response to insult from a myriad of conditions including infection (7) . Pediatric SIRS criteria were subsequently developed and include age-adjusted normative values for temperature, heart rate, respiratory rate, and WBC count (8) . Randomized trials in adult and pediatric transport patients have shown improved outcomes with increased use of out-ofhospital interventions (3, 9) . Although goal-directed therapy has become common practice in academic institutions, this approach has not been widely used outside tertiary care centers (10) . We hypothesized that the institution of goal-directed therapy by a specialized pediatric transport team during interfacility transport would improve the outcomes of critically ill patients with SIRS and SIRS-induced shock.
METHODS
This clinical trial was registered with ClinicalTrials.gov prior to patient enrollment (NCT 01293500). A prospective, single center, controlled before-and-after study compared study groups prior to and after institution of a goal-directed resuscitation protocol for transport of critically ill patients with SIRS and SIRS-induced shock. The study was approved by the University of Arkansas for Medical Sciences Institutional Review Board, which waived the need for informed consent. In lieu of informed consent, an informational sheet describing the study was provided to parents on arrival of the transport team at each outside facility.
Preliminary data were collected on all transport patients meeting inclusion/exclusion criteria over a 10-month period. Demographic data as well as data for illness severity, hospital length of stay (LOS), ICU LOS, prevalence of multiple organ dysfunction syndrome (MODS), need for therapeutic ICU interventions, and mortality were collected. The Pediatric Logistic Organ Dysfunction (PELOD) Scoring System was used to estimate the prevalence of MODS. PELOD scores have been validated as a reliable measure of MODS in critically ill children (11, 12) . The Therapeutic Intervention Scoring System (TISS)-28 scores were collected as an indicator of needed ICU interventions. TISS-28 scores are validated for use in pediatric patients and are commonly used in clinical studies as a measure of therapeutic interventions in critically ill children (13, 14) . These scores are also used as a measure of needed bedside nursing time, with one point on the TISS-28 scale equivalent to 10.6 minutes of each 8-hour shift. Following initial data collection, goal-directed protocolized resuscitation of patients with SIRS was instituted. All transport personnel were educated on the use of goal-directed resuscitation over a 6-week period via lectures and case scenarios using high-fidelity simulation until mastery was achieved. Following this period of teaching, transport patients with SIRS and SIRSinduced shock were resuscitated using this approach (Fig. 1) . Data were collected over a second 10-month period followed by comparison of pre-and postintervention groups. Care provided by outside facilities was not standardized in either group. All transport calls were taken by board-certified pediatric critical care physicians who provided suggested interventions based on perceived patient acuity.
Selection and Description of Participants
Consecutive pediatric patients who were 1 month to 17 years old meeting age-adjusted SIRS criteria were enrolled. All patients were interfacility transports by the Angel One Transport team from outside referring facility emergency departments to Arkansas Children's Hospital (ACH). The Angel One Transport team is a specialized pediatric interfacility transport team based at ACH, servicing the entire state of Arkansas and surrounding states. Transport team personnel included a registered respiratory therapist, a registered nurse, and a resident (Post-Graduate Level-2 or higher) or a fellow-level (Pediatric Critical Care or Pediatric Emergency Medicine) physician, all with critical care experience. Patients were defined as having SIRS if they met previously published consensus criteria (8) . Patients were excluded for any of the following reasons: 1) known or suspected congenital heart disease, 2) known or suspected cardiomyopathy or myocarditis, 3) diabetic ketoacidosis, 4) traumatic brain injury, 5) burn injury, or 6) known or suspected active hemorrhage.
The primary outcome was to determine if institution of goal-directed therapy during interfacility pediatric transport reduced hospital LOS for critically ill pediatric patients with SIRS or SIRS-induced shock. Secondary outcomes included reduction in ICU LOS, prevalence of MODS, and need for therapeutic ICU interventions. Additionally, cerebral oxygenation numbers obtained by means of near-infrared spectroscopy (NIRS) were collected on a convenience sample of patients among both groups to determine if this methodology can be used as a resuscitation guide during transport of critically ill pediatric patients with SIRS and SIRS-induced shock.
Statistical Methods
Multivarible linear model analyses using ordinary least squares were used for the analysis of hospital LOS and ICU LOS (15) . Models were adjusted for covariates: gender, race, age, and Pediatric Index of Mortality (PIM)-2 score. Restricted cubic splines were fit for PIM-2 score and transport time.
For the secondary outcome, reduced prevalence of MODS as measured by the PELOD score, repeated-measures mixed model analyses were used. This modeling strategy allows handling correlations between repeated measures taken on the same child; additionally, it is adapted to situations where the number of observations differs by participant (16) . The correlation structure used to describe correlations among repeated measures was compound symmetry, and the Kenward-Roger approximation to the degrees of freedom was used. The response variable was the PELOD score, and covariates included first PELOD score, PIM-2 score, gender, race, intervention period, ICU days, and the interactions between intervention days/first PELOD and intervention days/predicted death. Three-way interactions between days, intervention period, and PIM-2; days, first PELOD, and intervention period; as well as the other two-way interactions were investigated but excluded. The final model selected was the random intercept and slope model in which each participant is allowed to have his/her own regression line. This model was selected as the best fit over the random intercept only model based on the likelihood ratio test.
The reduction in TISS-28 score during ICU stay was investigated using repeated-measures mixed model analyses in a similar way as described for the PELOD analysis. Covariates included first TISS-28 score, PIM-2 score, gender, race, intervention period, ICU days, and the interactions between intervention days/first TISS-28 score and days/predicted death. Three-way interactions between days, intervention period, and PIM-2; days, first TISS-28, and intervention period; as well as the other two-way interactions were investigated but excluded. The final model selected is the random intercept and slope model in which each participant is allowed to have his/her own regression line. This model was selected because the random intercept only model did not converge.
Descriptive statistics and multivariable linear model analyses were performed using statistical software R version 2.15 (R Foundation for Statistical Computing, Vienna, Austria) (17) and the rms package (18) . SAS Version 9.3 (SAS Institute, Cary, NC) was used for the mixed model analyses. All tests performed were two sided, and p values less than 0.05 were considered statistically significant.
Power Calculation
Sample size was calculated prior to study initiation. We estimated that at least 83 patients needed to be enrolled per intervention period in order to detect a 2-day reduction in hospital LOS. This sample size was based on a two-sided t test with α = 0.05 and 90% power, assuming a common sd. Preliminary data available before study initiation showed a mean hospital LOS of 8.55 ± 3.47 days (mean ± sd) for pediatric patients with SIRS. For this sample size calculation, the 80% upper limit of the CI for the sd was used, giving an estimate of 3.94 for sd.
RESULTS
There were 242 eligible transport encounters during the study period, corresponding to 235 unique patients. Seven patients had two different transport encounters. Each transport encounter was considered an independent observation for modeling purposes, so the sample size studied was 242 participant encounters, with 127 observations in the preintervention period and 115 in the postintervention period.
Demographic and clinical characteristics of the study participants were similar at baseline ( Table 1 ). There were no significant differences for baseline characteristics except transport time (preintervention, 94 ± 34 min vs postintervention, 85 ± 31 min; p = 0.04) and for the outcome hospital LOS (preintervention, 11 ± 15 d vs postintervention, 7 ± 10 d; p = 0.02). Statistical differences were addressed using two-sample t tests for continuous variables and a Fisher exact test for categorical variables. For modeling purposes, other and Hispanic races were combined.
Transport Interventions
The amount of fluid resuscitation given during transport was not significantly different before and after protocol implementation (preintervention, 15.9 ± 15.4 mL/kg vs postintervention, 16.1 ± 20.2 mL/kg; p = 0.46). All subjects received at least maintenance IV fluids during transport. For those patients with more than 10% predicted mortality (PIM-2), there was a trend toward enhanced fluid resuscitation (preintervention, 15.9 ± 15.3 mL/kg vs postintervention, 41.1 ± 41.5 mL/kg; p = 0.09) following protocol implementation. Six subjects in the postintervention group received inotropic support (dopamine titrated to 10 μg/kg/min or epinephrine at 0.1 μg/kg/min) administered through a peripheral IV catheter.
Hospital LOS
There was a significant reduction of hospital LOS (p = 0.02) in the postintervention group. On average, patients in the postintervention period spent 3.5 less days in the hospital after adjusting for covariates (95% CI, 0.02-6.9 d). Normality assumptions could not be met secondary to the wide range of LOS, so a log transformation was investigated. The logtransformed model showed a significant effect of intervention period on hospital LOS (p = 0.03). On average, patients in the postintervention period spent 1.6 less days in the hospital after adjusting for covariates (95% CI, 1.3-2.03 d).
ICU LOS
There appeared to be a trend toward reduced ICU LOS in the postintervention group, with an estimated effect of 2.1 days (95% CI, 0.4-4.7 d). However, this difference was not statistically significant (p = 0.08). A log transformation was also explored to assess differences for ICU LOS; however, the effect of intervention on ICU LOS remained nonsignificant (p = 0.21).
Prevalence of MODS
PELOD scores were calculated daily for all patients in the ICU. Results of mixed models indicated a decline in PELOD scores during ICU stay (Fig. 2) , dependent on the first PELOD score (estimate (β) = 0.59; se = 0.04; p < 0.001) and on PIM-2 score (β = 2.03; se = 0.98; p = 0.04). Additionally, PELOD scores overall were lower in the postintervention period (β = 1.03; se = 0.55; p = 0.06), but rate of decline between pre-and post-PELOD scores was not significantly different (β = 0.07; se = 0.22; p = 0.75).
Needed Therapeutic Interventions
Mean first TISS-28 scores were lower in the postintervention group (17.3 ± 6.6 vs 19.4 ± 6.8; p = 0.04). Results of mixed models indicated a decline in TISS-28 scores during ICU stay (Fig. 3) , dependent on the first TISS-28 score (β = -0.04; se = 0.01; p = 0.002).
Cerebral Oxygenation
Cerebral oxygenation monitoring using NIRS technology was conducted on a convenience sample (n = 39; 20 preintervention and 19 postintervention) of patients. The NIRS device used was the INVOS 5100C monitoring device (Covidien, Boulder, CO). A single probe was placed on the center of the forehead. NIRS saturations using this method have been shown to trend with invasive monitoring of tissue oxygen delivery (19) . Somatic monitoring was not used in the present study. Previous research suggests that these numbers may not adequately reflect tissue oxygen delivery in patients over 10 kg (20) . Subjects less than 10 kg were monitored with a neonatal/infant-sized probe. All others were monitored with a standard-sized probe. The use of NIRS monitoring during pediatric interfacility transport has previously been shown to be effective during transport of patients via helicopter (21) . Monitoring commenced after arrival of the transport team at the outside facility and continued until arrival at the receiving facility. Subjects in the goal-directed therapy group had statistically higher cerebral oxygenation numbers on average than those in the preintervention group (71 ± 18 vs 66 ± 14; p < 0.05).
DISCUSSION
The present study is the first to provide evidence that the use of goal-directed therapy by specialized pediatric transport teams in the field improves the outcomes of critically ill children. Previous retrospective data have shown that transport of critically ill pediatric patients by specialized pediatric transport teams results in fewer complications and improved outcomes (1) . Goal-directed therapy has been instrumental in improving outcomes of critically ill patients with sepsis and septic shock (4) (5) (6) . Rapid deployment of specialized teams capable of delivering state-of-the-art critical care may be more beneficial than rapid delivery of critically ill patients to tertiary care centers. Specialized pediatric transport teams should be armed with evidence-based interventions, capable of being delivered to critically ill patients prior to and during interfacility transport.
In the present study, subjects in the goal-directed therapy group had a shorter length of hospital stay than those not receiving protocolized goal-directed therapy. The protocol ( Fig. 1 ) used in this study was constructed based on the current best available evidence for resuscitation and treatment of pediatric patients with severe sepsis and septic shock (6) . Prior to institution of protocolized resuscitation, patients were treated based on suggested interventions by medical control physicians, one of 10 board-certified pediatric intensivists. These guidelines call for interventions aimed at enhancing tissue oxygen delivery in the face of increased tissue oxygen demand. These early interventions include rapid IV fluid resuscitation, early administration of inotropic agents via peripheral IV, and correction of electrolyte abnormalities including abnormal serum glucose and calcium levels. These interventions were accomplished in the goal-directed therapy group in the present study. Additionally, during transport, pulse oximetry was maintained greater than 95%, continuous vital signs were measured, oscillometric blood pressure readings were obtained every 3-5 minutes, and threshold ageadjusted heart rates were maintained with continued fluid resuscitation in route. Subjects did not receive significantly different amounts of fluid resuscitation based on group assignment (15.91 ± 15.35 mL/kg [pre] vs 16.13 ± 20.17 mL/kg [post]; p = 0.46). All subjects received at least maintenance IV fluids. This held true with all patients regardless of initially severity of illness. Subjects in the goal-directed therapy group with PIM-2 scores greater than 10% did show a trend toward enhanced amounts of fluid resuscitation that was not statistically significant (15.91 ± 15.35 mL/kg [pre] vs 41.05 ± 41.52 mL/kg [post]; p = 0.09). Six subjects (all in the goal-directed therapy group) received peripherally administered inotropic agents during transport. It is likely that a combination of factors leading to overall improved quality of care and enhanced tissue oxygen delivery during transport led to the observed outcome differences.
Subjects in the goal-directed therapy group required fewer initial ICU interventions, as evidenced by lower TISS-28 scores. Additionally, they had lower PELOD scores and a trend toward shorter ICU LOS, although the present study was not powered to detect such a difference. These differences were seen despite similar initial PIM-2 scores, further suggesting the importance of rapid and appropriate interventions during interfacility transport. Although PELOD scores were different, the rates of decline after ICU admission were similar in both groups, emphasizing the need for continued ICU care and suggesting that patients in the goal-directed therapy group were more adequately resuscitated on ICU arrival. Overall mortality was 2% (2 preintervention; 3 postintervention).
Cerebral oxygenation monitoring using NIRS technology was conducted on a convenience sample of patients in this study. Cerebral oxygenation numbers have been shown to trend with invasive measures of mixed venous saturation (SVo 2 ) (19) . SVo 2 numbers are a direct reflection of adequacy of tissue oxygen delivery, but currently require invasive ICU monitoring. Cerebral oxygenation monitoring is a noninvasive tool with the potential for use as a guide for resuscitation prior to ICU arrival. Subjects in the goal-directed therapy group had statistically higher cerebral oxygenation numbers during transport than those in the control group (71 ± 18 vs 66 ± 14; p < 0.05). Although this difference may not be clinically significant, future studies should evaluate the potential of this noninvasive tissue oxygen delivery monitoring tool to guide resuscitative interventions during interfacility transport.
Limitations of the current study include its single center nature and before-and-after intervention design. The Angel One Transport team at ACH is a specialized pediatric interfacility transport team with a composition similar to other specialized interfacility transport teams across the country, except for physician presence on the ACH team during the study period. Physicians were present during both pre-and postintervention periods. The team has conducted other clinical trials in the out-of-hospital setting (3, 21) . The method of resuscitation used in this study would be easy to institute among specialized pediatric transport teams at other institutions. The before-and-after design of this study lends itself to the possibility of overall improved care during the study period. Although we realize this limitation, randomization after teaching goaldirected resuscitation to the team was not possible. In addition, the nonnormative distribution of the LOS data may have overestimated the benefit of goal-directed therapy. The findings of this study should be confirmed across other institutions, but suggest that improved care delivered by specialized pediatric interfacility transport teams has the potential to impact the clinical outcomes of critically ill children with SIRS.
CONCLUSIONS
Specialized pediatric transport teams have evolved into mobile ICUs capable of delivering definitive care to critically ill children during interfacility transport. Arming these teams with goal-directed therapeutic protocols has the potential to impact the outcomes of critically ill children. Continued research efforts should seek to develop evidence-based therapies to be administered by specialized pediatric transport teams in the field prior to tertiary care center arrival. In addition, training outside facility healthcare providers in goal-directed therapy may further improve care for these children.
